Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Fate Therapeutics, Inc.”

40 pharma patents match "Fate Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 40
Index total 30,257
Page 2 / 2

Quick answer

This filtered view shows 40 pharmaceutical patents matching "Fate Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

40 results for “Fate Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 10980838

    Methods of treating ischemia

    Fate Therapeutics, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  2. US 10954529

    Minimal volume reprogramming of mononuclear cells

    Fate Therapeutics, Inc. · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted
  3. US 10947505

    Methods and compositions for inducing hematopoietic cell differentiation

    Fate Therapeutics, Inc. · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  4. US 10927346

    Enhanced immune effector cells and use thereof

    Fate Therapeutics, Inc. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  5. US 10858628

    Methods and compositions for inducing hematopoietic cell differentiation

    Fate Therapeutics, Inc. · Granted Dec 8, 2020 · Expires Dec 3, 2040

    granted
  6. US 10851412

    Cell potency assay for therapeutic potential

    Fate Therapeutics, Inc. · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  7. US 10626372

    Methods and compositions for inducing hematopoietic cell differentiation

    Fate Therapeutics, Inc. · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted
  8. US 10287606

    Genomic engineering of pluripotent cells

    Fate Therapeutics, Inc. · Granted May 14, 2019 · Expires May 9, 2039

    granted
  9. US 10172888

    Enhanced stem cell composition

    Fate Therapeutics, Inc. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  10. US 10111907

    Methods of treating ischemia

    Fate Therapeutics, Inc. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted
  11. US 10023879

    Minimal volume reprogramming of mononuclear cells

    Fate Therapeutics, Inc. · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted
  12. US 9943545

    Stem cell culture media and methods of enhancing cell survival

    Fate Therapeutics, Inc. · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted
  13. US 9873722

    Wnt compositions and therapeutic uses of such compositions

    Fate Therapeutics, Inc. · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  14. US 9452186

    Enhanced stem cell composition

    Fate Therapeutics, Inc. · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted
  15. US 9403885

    Wnt compositions and therapeutic uses of such compositions

    Fate Therapeutics, Inc. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  16. US 9370510

    Small molecule compounds to treat hearing loss

    Fate Therapeutics, Inc. · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted